Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes

New England Retina Associates

Status: Completed

Conditions: Age Related Macular Degeneration; Epiretinal Membrane

Study type: Observational

Funder types: Other

Identifiers

NCT01846351

NAC270608

Details and patient eligibility

About

Study designed to evaluate the effect of significant ERM on the visual and anatomic outcomes of intravitreal anti-VEGF therapy for eAMD.

Full description

Gass in 1987 described three cases of epiretinal membrane (ERM) associated with wet macular degeneration. Since then we have seen that is not rare to find the coexistence of these entities. An ERM may produce intrinsic disorganization of the outer retina leading to persistent increased macular thickness and/or edema. This persistent edema may affect the effectiveness in the treatment of exudative age-related macular degeneration (eAMD). Therefore, this study was designed to evaluate the effect of significant ERM on the visual and anatomic outcomes of intravitreal anti-VEGF therapy for eAMD.

Enrollment: 16 patients

Sex: All

Ages: 58 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Significant epiretinal membrane
• Anti-VEGF treatment for age-related macular degeneration

Exclusion criteria

• Uveitis
• Macular disorders
• Diabetic retinopathy
• Vascular occlusions